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"In both [types of icterus] ... the whole body is itchy ... the bilious particles
being prickly" [1].
Pruritus in hepatobiliary disease is commonly believed to be caused by retention of bile acids with their
sequestration in the skin. However, we have recently demonstrated that skin levels of bile acids in patients
with cholestasis correlate poorly with pruritus. In this report, we present additional data concerning the
relationship ofpruritus to bile acid retention: (1) the urinary excretion ofsulfated and nonsulfated bileacids
was not significantly different inpatients with cholestasis who itched compared to those who did not; (2) one
patient with itch associated with a liver abscess had normal levels of bile acids in serum, skin, and urine; (3)
patients with primary biliary cirrhosis who itched had lower serum bile acid levels than patients with
mechanical biliary obstruction who did not itch.
These studies support our premise that pruritus in hepatobiliary diseases is not directly related to bileacid
retention. They suggest that the type ofcholestatic disorder, and not simply the magnitude ofthe cholestasis,
as estimated by the elevation of serum bile acids, is important. We propose that the agent responsible for
pruritus is produced in response to cholestasis, possibly through activation ofthe alternate pathway of bile
acid synthesis. Properties of the hypothetical pruritogen are discussed.
INTRODUCTION
Itch is a frequent and very troublesome symptom in many types of liver disease,
particularly those with prominent cholestatic features, such as biliary obstruction,
primary biliary cirrhosis, and congenital cholestatic syndromes [2]. It is rare however
in other types ofliver disease, most notably alcoholic liver disease, even when severe
cholestasis is present.
Since the demonstration in 1960 that the bile salt binding agent cholestyramine
effectively relieves the itch of cholestasis, and concomitantly lowers serum bile salt
concentrations [3], it has been widely assumed that retention of bile salts, with their
deposition in the skin, is related in some way to the development of the pruritus.
Although this assumption has several inconsistencies and has been seriously chal-
77
Presented at "A Scientific Program on Liver Disease Honoring Dr. Gerald Klatskin, David Paige Smith Professor of
Medicine and Chief, Yale Liver Unit," which was held at the Yale University School ofMedicine, June 1-2, 1978. Joseph
R. Bloomer, M.D., is guest editor.
This work was done at Yale while the first author was the recipient offellowships from the Canadian Foundation for
Diseases of the Liver and the McLaughlin Foundation, whose support is gratefully acknowledged. Dr. Bloomer is an
Investigator of the Howard Hughes Medical Institute.
Address reprint requests to: Dr. C.N. Ghent, Assistant Professor of Medicine, Department of Medicine, University
Hospital, University of Western Ontario, 339 Windermere Road, London, Ontario, Canada N6A 5A5
0044-0086/79/5201-0077 $00.60
Copyright i 1979 by The Yale Journal of Biology and Medicine, Inc.
All rights of reproduction in any form reserved.GHENT AND BLOOMER
lenged by the demonstration that skin levels ofbile acids in patients with cholestasis
correlate poorly with pruritus [4], there has been no reasonable alternative candidate
for the role of cholestatic pruritogen.
The evidence for and against a role for bile acid retention as a cause ofcholestatic
itch is summarized in Table 1. Theoretical objections to assigning the role of
cholestatic pruritogen to bile salts have been previously stated [4]. Some further
considerations will be given here.
Although purified bileacids have produced itch wheninjected into skinblisters [8],
or applied to dekeratinized skin at acid pH [9], in both studies unconjugated bile
acids were found to be more pruritogenic than conjugates, and dihydroxy bile acids
more frequently produced itch than did cholic acid. Based on these considerations,
one would expect to see pruritus predominantly in diseases associated with retention
of unconjugated bile acids, and those with a predominance ofdihydroxy bile acids.
These conditions are found in the stagnant loop syndrome [15], but these patients do
not itch. In cholestatic liver disease, unconjugated bile acids are seldomdetectable in
serum [4,7]. Dihydroxy bile acids predominate in the serum in those liver diseases
infrequently associated with pruritus, most notably alcoholic liver disease in all stages
[16], and in advanced cirrhosis of all types [17]. Therefore, the experimental
production of pruritus with bile salts must be interpreted with caution.
The effect of cholestyramine may not be mediated by its effects on bile acid
metabolism, since it also relieves the pruritus of polycythemia rubra vera [18], and
uremia [19].
We have studied further the possible relationship between bile acid retention and
itch by measurement of serum and urinary bile acid concentrations, including
separate quantitation of sulfated and nonsulfated bile acids in the urine, and could
not demonstrate a relationship between pruritus and serum or urinary levels of any
major bile acid.
METHODS AND PATIENTS
All patients were evaluated at Yale-New Haven Hospital. Itch was evaluated as
previously reported [4], and fasting serum and 24 hour urine specimens were
obtained.
Serum bile acids were measured as described previously [4]. For measurement of
urinary bile acid excretion an aliqot of 5 to 100 ml ofurine was alkalinized to pH 11
with 1 N sodium hydroxide and slowly percolated through a 1 x 10 cm column of
SM-2 (XAD-2) [20]. Bile acids were eluted with 100 ml ofmethanol, which wasflash
TABLE I
Conflicting Data about the Relationship Between Itch and Bile Salt Retention in Cholestasis.
For a fuller discussion, see text.
For Against
1. Relief with cholestyramine [3,5] 1. Poor correlation with serum bile salts [4,10,11,12]
2. Correlation with serum bile salt levels 2. Relief with phenobarbital treatment without
in certain diseases [6,7] a decrease in serum bile acids [13]
3. Experimental production of itch with pure 3. Relief with androgen therapy with a
bile salts [8,9] rise in serum bile acids [7,14]
4. Correlation with skin surface bile salt 4. Lack of correlation with skin tissue levels
concentrations [10,11] of bile acids [4]
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TABLE 2
Urinary Sulfated and Nonsulfated Bile Acid Excretion (mg/24 hr) in Biliary Obstruction (Mean and Range). One
patient with itch had pruritus gravidarum; all of the others had mechanical biliary obstruction.
Itch No Itch p
No. of Patients 5 6
Sulfates 9.8 (0.4-15.9) 5.8 (0.8-15.5) NS
Nonsulfates 9.7 (0.8-23.3) 5.1 (1.9-12.2) NS
Total (mg/24 hr) 19.5 (1.9-39.1) 10.9 (2.7-17.7) NS
evaporated. The residue was reconstituted in 2.0 ml of chloroform: methanol 1:1;
sulfated and nonsulfated bile acids were separated by column chromatography using
1 x 25 cm columns of Sephadex LH-20 [21]. After addition of internal standard, the
bile acids were quantified using the same method as for serum samples.
RESULTS
The urinary excretion of bile acids in patients with cholestasis, in relation to the
presence or absence of itch, is presented in Table 2. Although patients with itch had
higher mean excretion of individual and total bile acids than those without itch, this
was not statistically significant because of the wide range of values.
The percent of total urinary bile acids present as sulfates was similar in all groups
(Table 3). As reported by others [21,22] most of the monohydroxy bile acids are
sulfated, but cholic acid is mostly unsulfated.
One patient (not included in the above) without cholestasis, but with itch
associated with liver disease, was particularly instructive. A 41-year-old diabetic lady
presented with a five week history ofdaily fevers and persistent itching. Investigation
revealed no evidence of cholestasis except for a serum alkaline phosphatase of 153
(normal 10-70 I.U.). A leukocytosis of 20,700 was present and a large right lobe
defect was demonstrated on liver scan. Three days after surgical drainage of a
staphlococcal liver abscess her itching disappeared. Analysis of preoperative serum
and a 24 hour urine specimen showed total serum bile acids of 1.6,4g/ml (normal less
than 2.0 ug/ml) and urinary excretion of less than 1.0 mg/24 hrs. (normal).
A skin specimen, obtained at surgery [4], contained only traces of bile acids. This
patient thus had itch associated with liver disease but no demonstrable bile acid
retention.
Analysis of serum bile acid data by disease category in relation to itch is shown in
Table 4. Within individual disease categories, the mean level was higher in patients
with pruritus. However, patients with mechanical biliary obstruction and no itch had
TABLE 3
Percent of Total Urinary Bile Acid Present as Sulfates (mean * SD). Numbers in brackets indicate the number of
patients studied. Controls were patients without cholestasis admitted for non-hepatobiliary surgery.
Monohydroxy Dihydroxy Trihydroxy Total
Cholestasis with
Pruritus (5) 80.6 i 33.1 66.8 * 24.5 24.2 i 18.4 46.7 i 13.1
Cholestasis without
Pruritus (6) 86.7 * 15.0 79.5 i12.6 20.5 i 15.1 51.5 i 16.8
Controls (8) 82.6 i 28.0 72.5 i 24.5 24.7 * 28.8 66.8 i 26.2
79GHENT AND BLOOMER
TABLE 4
Serum Bile Acid Levels by Disease Category (jug/ ml). The miscellaneous group includes four subjects with pruritus
gravidarum, two with alcoholic liver disease, and 5 with congenital cholestatic syndromes.
Itch No Itch
Number Mean i SEM Number Mean i SEM p
Primary Biliary Cirrhosis 34 25.6 ± 4.0 15 13.5 ± 3.7 <0.01
Mechanical Biliary Obstruction I1 90.8 ± 5.2 9 33.2 ± 4.3 <0.005
Miscellaneous Cholestatic Diseases 14 54.1 ± 7.9 - - -
higher serum bile acid levels than did patients with primary biliary cirrhosis who
itched.
DISCUSSION
The absence of a significant difference in bile acid excretion in patients with
cholestasis and itch compared to those without itch (Table 2) makes it unlikely that
urinary excretion of bile acids is a protective mechanism with respect to pruritus, as
suggested previously [11]. There was also no difference in the fraction ofurinarybile
acids present as sulfates in the two groups of patients (Table 3). Therefore it is
unlikely that large differences in the retention of either sulfated or nonsulfated
fractions could correlate with pruritus. Peak serum bile acid levels occur postprandi-
ally, but we used fasting levels because they correlate well with skin levels [4].
Since the levels of serum bile acids in different disease categories inwhich pruritus
occurs are quite dissimilar(Table 4), the type ofhepatobiliary disease, and not simply
the magnitude of the cholestasis, may be an important determinant of itch. It is
possible that a pruritogen is produced in cholestasis, and that production of this
pruritogen begins at different levels of cholestasis, depending on the underlying
disease and the mechanism of the cholestasis.
The pruritogen produced in response to cholestasis must possess certain properties
(Table 5). One possibility is that thepruritogen is produced as a result of"activation"
of the alternate pathway-of bile acid synthesis beginning with 26-hydroxylation of
cholesterol (Fig. 1). Bile acid synthetic pathways in man are incompletely under-
stood. However, the major pathway, which begins with 7a-hydroxylation of choles-
terol, results in microsomal alterations of the cholesterol steroid nucleus before
mitochondrial oxidation of the side chain[23]. The existence ofan alternate pathway
in man, in which primary oxidation ofthe side chain precedes changes in the steroid
nucleus, is inferred because ofthe presence in cholestasis of3-.-cholest-5-ene-24-oic
acid, in which the cholesterol nucleus is unchanged [4,24,25]. This pathway is
demonstrable in patients with a bile fistula [26].
The known correlates of cholestatic pruritus are compatible with the above
hypothesis. Cholestyramine administration enhances bile salt synthesis by the 7a-
hydroxylase pathway [27], and perhaps thereby decreases activity of the alternate
TABLE 5
Properties of Hypothetical Cholestatic Pruritogen
1. Excreted in cholestatic bile.
2. Production and/or excretion affected by therapy with cholestyramine, phenobarbital [24], estrogens [25],
androgens (26], and possibly thyroxine [28].
3. Dependent on relatively good parenchymal liver function.
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FIG. 1. Simplified schematic diagram of possible bile acid biosynthetic pathways in man. The "alternate" pathway
on the right is primarily mitochondrial, and appears to be activated in cholestasis, as evidenced by accumulation of
compound VI.
pathway. Alternatively it may enhance biliary excretion of the pruritogen by
stimulation of bile-salt-dependent bile flow. Phenobarbital [27,28], estrogens[29,30],
and androgens [30] all interact with the bile salt synthetic pathways, although effects
of these on the "alternate" synthesis pathway are unknown. The rarity of itch in
alcoholic liver disease may also be explained by this hypothesis. Since it requires
intact mitochondrial cholesterol side chain oxidation to "activate" the alternate
pathway, the pruritogen may not be synthesized in those hepatic diseases where
mitochondrial damage is a prominent feature. Alcoholic liver disease is such a
condition [31].
Pruritus in thyrotoxicosis is associated with elevations of serum levels ofchenode-
oxycholic acid [32]. It is of interest that thyroxine also stimulates cholesterol 26-
hydroxylase [33], in view of the above hypothesis.
If this hypothesis is correct, then bile acid synthesis by the alternate pathway must
begin at a different level of cholestasis in extrahepatic biliary obstruction than in
primary biliary cirrhosis (Table 4). The pruritogen should beidentifiable as one ofthe
intermediates or products of this pathway. In this, and our previous study [4], we
were unable to find a correlation ofpruritus with one such compound, 3-f-cholest-5-
ene-24-oic acid. Therefore the hypothesis has no direct proof.
Other possibilities can beformulated. Forexample, it is intriguing to speculate that
a final common pathway may exist to cause pruritus in cholestasis, uremia, and
polycythemia, since these conditions all respond to cholestyramine administration
[18,19]. Similar vascular and/or hormonal changes might occur in all of these
conditions, or the same pruritogenic compound might be produced.
REFERENCES
1. Aretaeus, the Cappadocian (circa 160 A.D.): The Extant Works of Aretaeus the Cappadocian. Edited by F Adams.
London, Sydenham Society, 185682 GHENT AND BLOOMER
2. McPhedran NT, Henderson RD: Pruritus and jaundice. Canad Med Assoc J 92:1258-1260, 1965
3. Carey JB Jr, Williams G: Relief of pruritus ofjaundice with a bile acid sequestering resin. JAMA 176:432-435, 1961
4. Ghent CN, Bloomer JR, Klatskin G: Elevations in skin tissue levels of bile acid in human cholestasis: Relation to
serum levels and to pruritus. Gastroenterology 73:1125-1130, 1978
5. Carey JB Jr: Lowering of serum bile acid concentrations and relief ofpruritus injaundiced patients fed a bile acid
sequestering resin. J Lab Clin Med 56:797-798, 1960
6. Bloomer JR, Allen RM, Klatskin G: Serum bile acids in primary biliary cirrhosis. Arch Intern Med 136:57-61, 1976
7. Osborne EC, Wooten IE, DiSalva LC, et al: Serum bile acid levels in liver disease. Lancet 2:1049-1053, 1959
8. Kirby J, Heaton KW, Burton JL: Pruritic effect of bile salts. Br Med J 4:693-695, 1974
9. Varadi DP: Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human
skin. Arch Dermatol 109:678-681, 1974
10. Schoenfield. LJ, Sjovall J, Perman E: Bile acids on the skin of patients with pruritic hepatobiliary disease. Nature
213:93-94, 1967
11. Stiehl A: Bile acids and bile acid sulfates in the skin of patients with cholestasis and pruritus. Z Gastroenterol
12:121-124, 1974
12. Murphy GM, Ross A, Billings BH: Serum bile acids in primary biliary cirrhosis. Gut 13:201-206, 1972
13. Ghent CN, BloomerJR, HsiaYE: Safety and efficacy oflongterm treatment offamilial intrahepatic cholestasis with
phenobarbital. J Pediatr 93:127-132, 1978
14. Alva J, Iber FL: Relief of pruritus ofjaundice with methandrostenolone and speculation on the nature ofpruritus in
liver disease. Am J Med Sci 250:60-65, 1965
15. Lewis B, Panveliwalla D, Tabaqchali S, et al: Serum-bile-acids in the stagnant-loop syndrome. Lancet 1:219-220,
1969
16. Milstein HJ, Bloomer JR, Klatskin G: Serum bile acids in alcoholic liver disease. Comparison with histologic
features of the disease. Amer Journ Dig Dis 21:281-285, 1976
17. Sherlock S: Cholestasis in Diseases of the Liver and Biliary System. 5th Edition. London, Blackwell Scientific
Publications, 1975, p 267
18. Chanarin I, Szur L: Relief of intractable pruritus in polycythemia rubra vera with cholestyramine. Br J Haematol
29:669-670; 1975
19. Silverberg DS, laina A, Rein E, et al: Cholestyramine in uremic pruritus. Brit Med Journal 1:752-753, 1977
20. Shinozaki K, Nakagawa S: Sulfated bile acids in urine of patients with hepatobiliary diseases. Lipids 8:47-49, 1973
21. Makino I, Shinozaki K, et al: Measurement ofsulfated and nonsulfated bile acids in human serum and urine. J Lipid
Res 15:132-138, 1974
22. Stiehl A: Bile salt sulfates in cholestasis. Europ J Clin Invest 4:59-63, 1974
23. Heaton K: Hepatic synthesis and metabolism of bile salts in Bile Salts in Health and Disease. Baltimore, Williams
and Wilkins Company, 1972, pp 52-57
24. Murphy GM, Jansen FH, Billing B: Unsaturated monohydroxy bile acids in cholestatic liver disease. Biochem
Journal 129:491-494, 1972
25. Back P: Identification and quantitative determination ofurinary bile acids excreted in cholestasis. Clinica Chimica
Acta 44:199-207, 1973
26. Anderson KE, Kok E, Javitt NB: Bile acid synthesis in man: Metabolism of 7a-hydroxycholesterol-14C and 26-
hydroxycholesterol3H. J Clin Invest 51:112-117, 1972
27. Shefer S, Hauser S, Mosbach EH: 7a-hydroxylation of cholestanol by rat liver microsomes. J Lipid Res 9:328-333,
1968
28. Redinger RN, Small DM: Primate biliary physiology VIII. The effect of phenobarbital upon bile salt synthesis and
pool size, biliary lipid secretion and bile composition. J Clin Invest 52:161-172, 1973
29. Javitt NB, Panveliwalla D, Morrisey K, et al: Ethinyl estradiol: Longterm effects on bile acid kinetics inthe baboon.
Trans Assoc Am Physicians 88:278-284, 1975
30. Danielsson H: Mechanisms of bile acid formation, Bile Salt Metabolism. Edited by L Schiff, JB Carey, JM
Dietschy. Springfield, III, Charles C Thomas, 1969, pp 91-102
31. Rubin E, Lieber CS: Experimental alcoholic hepatic injury in man: Ultrastructural changes. Federation Proceedings
26:1458-1467, 1967
32. Kinsey MD, Donowitz M, Wartofsky L, et al: The correlation between Pruritus and elevated serum chenodeoxy-
cholic acid levels in hyperthyroidism. Gastroenterology 70:A-44/902, 1976
33. Bekersky I, Mosback EH: Effect of hormones on bile acid metabolism, The Bile Acids, Vol. 2. Edited by PO Nair,
D Kritchevsky. New York, Plenum Press, 1973, pp 243-257